Humacyte
(NASDAQ:HUMA)
$3.94
0.02[0.51%]
At close: Apr 30
$3.94
0[0.00%]
PreMarket: 7:15PM EDT

Humacyte Stock (NASDAQ:HUMA), Quotes and News Summary

Humacyte Stock (NASDAQ: HUMA) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.21.000 / 1.343M
Day Range- - -
52 Wk Range1.960 - 5.600
Market Cap$469.190M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
63
Short Interest
5.07%
Days to Cover3.41
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Nov 23
2
Dec 23
1
2
Mar
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
HUMA
CABA

FAQ

Q

How do I buy Humacyte (HUMA) stock?

A

You can purchase shares of Humacyte (NASDAQ: HUMA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Humacyte's (HUMA) competitors?

Q

What is the target price for Humacyte (HUMA) stock?

A

The latest price target for Humacyte (NASDAQ: HUMA) was reported by Cantor Fitzgerald on Monday, April 1, 2024. The analyst firm set a price target for 7.00 expecting HUMA to rise to within 12 months (a possible 77.66% upside). 13 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Humacyte (HUMA)?

A

The stock price for Humacyte (NASDAQ: HUMA) is $3.94 last updated April 30, 2024 at 7:15 PM EDT.

Q

Does Humacyte (HUMA) pay a dividend?

A

There are no upcoming dividends for Humacyte.

Q

When is Humacyte (NASDAQ:HUMA) reporting earnings?

A

Humacyte’s Q1 earnings are confirmed for Tuesday, May 14, 2024.

Q

Is Humacyte (HUMA) going to split?

A

There is no upcoming split for Humacyte.

Q

What sector and industry does Humacyte (HUMA) operate in?

A

Humacyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch